Ray and colleagues' retrospective cohort study used automated access to data to evaluate patients who had received clopidogrel during a focused analysis from 1999 to 2005 in a Tennessee Medicaid ...

Secondary prevention with aspirin and clopidogrel reduces cardiovascular events. Because of variable response to clopidogrel and a persistent risk of cardiovascular events, new strategies and novel ...

Because of recently updated recommendations by the American College of Cardiology Foundation and American Heart Association about how to treat patients with cardiovascular disorders with antiplatelet ...

CHICAGO, IL—Data from a new study provide yet more support for the use of single antiplatelet therapy (SAPT) after TAVI, with investigators concluding that dual antiplatelet therapy (DAPT) should be ...

Please provide your email address to receive an email when new articles are posted on . Compared with no antiplatelet therapy, aspirin and P2Y12 inhibitors did not improve the number of organ ...

Researchers have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet medications currently available. A new study ...

Existing practice surrounding many cardiovascular medications, including anti-hypertensive and lipid-lowering agents, is based on the evaluation of response to therapy. In cases where ideal ...

New data from an observational study provide some support for antiplatelet therapy in patients with moyamoya disease, a rare arteriopathy characterized by progressive stenosis of the distal internal ...

Although seemingly inappropriate, antiplatelet therapy could benefit patients who have survived intracerebral hemorrhage (ICH) and are therefore at risk of recurrent ICH. The decision to prescribe ...

Predicting drug-induced liver injury continues to be a challenge, especially when reports of severe hepatotoxicity associated with certain drugs are rare. Predicting drug-induced liver injury ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...